Literature DB >> 19631025

Experimental rat models to study the metabolic syndrome.

Amaya Aleixandre de Artiñano1, Marta Miguel Castro.   

Abstract

Being the metabolic syndrome a multifactorial condition, it is difficult to find adequate experimental models to study this pathology. The obese Zucker rats, which are homozygous for the fa allele, present abnormalities similar to those seen in human metabolic syndrome and are a widely extended model of insulin resistance. The usefulness of these rats as a model of non-insulin-dependent diabetes mellitus is nevertheless questionable, and they neither can be considered a clear experimental model of hypertension. Some experimental models different from the obese Zucker rats have also been used to study the metabolic syndrome. Some derive from the spontaneously hypertensive rats (SHR). In this context, the most important are the obese SHR, usually named Koletsky rats. Hyperinsulinism, associated with either normal or slightly elevated levels of blood glucose, is present in these animals, but SHR/N-corpulent rats are a more appropriated model of non-insulin-dependent diabetes mellitus. The SHR/NDmc corpulent rats, a subline of SHR/N-corpulent rats, also exhibit metabolic and histopathologic characteristics associated with human metabolic disorders. A new animal model of the metabolic syndrome, stroke-prone-SHR (SHRSP) fatty rats, was obtained by introducing a segment of the mutant leptin receptor gene from the Zucker line heterozygous for the fa gene mutation into the genetic background of the SHRSP. Very recently, it has been developed as a non-obese rat model with hypertension, fatty liver and characteristics of the metabolic syndrome by transgenic overexpression of a sterol-regulatory element-binding protein in the SHR rats. The Wistar Ottawa Karlsburg W rats are also a new strain that develops a nearly complete metabolic syndrome. Moreover, a new experimental model of low-capacity runner rats has also been developed with elevated blood pressure levels together with the other hallmarks of the metabolic syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19631025     DOI: 10.1017/S0007114509990729

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  88 in total

Review 1.  Laboratory animals as surrogate models of human obesity.

Authors:  Cecilia Nilsson; Kirsten Raun; Fei-fei Yan; Marianne O Larsen; Mads Tang-Christensen
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

Review 2.  Sleep and obesity: a focus on animal models.

Authors:  Vijayakumar Mavanji; Charles J Billington; Catherine M Kotz; Jennifer A Teske
Journal:  Neurosci Biobehav Rev       Date:  2012-01-16       Impact factor: 8.989

3.  Metabolic syndrome impairs reactivity and wall mechanics of cerebral resistance arteries in obese Zucker rats.

Authors:  Steven D Brooks; Evan DeVallance; Alexandre C d'Audiffret; Stephanie J Frisbee; Lawrence E Tabone; Carl D Shrader; Jefferson C Frisbee; Paul D Chantler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

4.  CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.

Authors:  Qian Zhang; Rosemarie Schmandt; Joseph Celestino; Adrienne McCampbell; Melinda S Yates; Diana L Urbauer; Russell R Broaddus; David S Loose; Gregory L Shipley; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-04       Impact factor: 5.482

5.  Enhanced nicotine self-administration and suppressed dopaminergic systems in a rat model of diabetes.

Authors:  Laura E O'Dell; Luis A Natividad; Joseph A Pipkin; Francisco Roman; Ivan Torres; Jesus Jurado; Oscar V Torres; Theodore C Friedman; John M Tenayuca; Arbi Nazarian
Journal:  Addict Biol       Date:  2013-07-08       Impact factor: 4.280

6.  Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.

Authors:  Jefferson C Frisbee; Matthew T Lewis; Jonathan D Kasper; Paul D Chantler; Robert W Wiseman
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

7.  Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes.

Authors:  Lu Han; Stefanie Bittner; Dachuan Dong; Yuan Cortez; Alex Bittner; Jackie Chan; Meenakshi Umar; Wen-Jun Shen; Richard G Peterson; Fredric B Kraemer; Salman Azhar
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-24       Impact factor: 5.187

8.  Strain differences in self-administration of methylphenidate and sucrose pellets in a rat model of attention-deficit hyperactivity disorder.

Authors:  Julie A Marusich; William Travis McCuddy; Joshua S Beckmann; Cassandra D Gipson; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2011-12       Impact factor: 2.293

Review 9.  Microvascular perfusion heterogeneity contributes to peripheral vascular disease in metabolic syndrome.

Authors:  Jefferson C Frisbee; Adam G Goodwill; Stephanie J Frisbee; Joshua T Butcher; Fan Wu; Paul D Chantler
Journal:  J Physiol       Date:  2014-12-18       Impact factor: 5.182

10.  Defective fasting-induced PKA activation impairs adipose tissue glycogen degradation in obese Zucker rats.

Authors:  Marcelo Flores-Opazo; Jennifer Trieu; Timur Naim; Denisse Valladares-Ide; Hermann Zbinden-Foncea; David Stapleton
Journal:  Int J Obes (Lond)       Date:  2019-01-31       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.